Ensuring the Safety and Efficacy of Biologics 

This year's Immunogenicity Stream focuses on the latest science, technologies and strategies to ensure the safety and efficacy of biologics, with particular focus on novel modalities including cell & gene therapies, bispecifics, multi-specifics, immunotherapies and ADCs. The Immunogenicity Assessment and Management conference presents case studies on assay development and validation, clinical relevance, drug and target interference, risk assessment and recent advances with predictive studies and tools. The conference is preceded by an in-depth introduction to immunogenicity training seminar and followed by an introduction to bioassay design and analysis.